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Background: The use of high accuracy dose calculation algorithms, such as Monte Carlo (MC) and Collapsed Cone
(CC) determine dose in inhomogeneous tissue more accurately than pencil beam (PB) algorithms. However,
prescription protocols based on clinical experience with PB are often used for treatment plans calculated with CC.
This may lead to treatment plans with changes in field size (FS) and changes in dose to organs at risk (OAR),
especially for small tumor volumes in lung tissue treated with SABR.
Methods: We re-evaluated 17 3D-conformal treatment plans for small intrapulmonary lesions with a prescription of
60 Gy in fractions of 7.5 Gy to the 80% isodose. All treatment plans were initially calculated in Oncentra MasterPlan®
using a PB algorithm and recalculated with CC (CCre-calc). Furthermore, a CC-based plan with coverage similar to the
PB plan (CCcov) and a CC plan with relaxed coverage criteria (CCclin), were created. The plans were analyzed in terms
of Dmean, Dmin, Dmax and coverage for GTV, PTV and ITV. Changes in mean lung dose (MLD), V10Gy and V20Gy were
evaluated for the lungs. The re-planned CC plans were compared to the original PB plans regarding changes in
total monitor units (MU) and average FS.
Results: When PB plans were recalculated with CC, the average V60Gy of GTV, ITV and PTV decreased by 13.2%,
19.9% and 41.4%, respectively. Average Dmean decreased by 9% (GTV), 11.6% (ITV) and 14.2% (PTV). Dmin decreased
by 18.5% (GTV), 21.3% (ITV) and 17.5% (PTV). Dmax declined by 7.5%. PTV coverage correlated with PTV volume
(p < 0.001). MLD, V10Gy, and V20Gy were significantly reduced in the CC plans. Both, CCcov and CCclin had significantly
increased MUs and FS compared to PB.
Conclusions: Recalculation of PB plans for small lung lesions with CC showed a strong decline in dose and
coverage in GTV, ITV and PTV, and declined dose in the lung. Thus, switching from a PB algorithm to CC, while
aiming to obtain similar target coverage, can be associated with application of more MU and extension of
radiotherapy fields, causing greater OAR exposition.
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1 1.6 2.0 RLL peripheral
2 1.6 3.5 RUL central
3 4.1 41.2 RUL peripheral
4 3.1 12.1 LLL peripheral
5 2.8 6.4 R central
6 1.5 1.4 RUL peripheral
7 1.2 4.6 RLL peripheral
8 2.5 3.8 R central
9 1.2 1.2 R central
10 2.6 15.2 RLL peripheral
11 3.0 17.0 LUL central
12 2.5 4.4 RUL peripheral
13 2.5 27.0 RLL peripheral
14 3.9 27.9 RLL peripheral
15 4.6 61.6 RLL central
16 1.8 4.7 RUL peripheral
17 4.0 36.2 LUL peripheral
†For the purpose of this study we defined tumors that were directly attached
to the mediastinum or pleura as peripheral and all others (fully surrounded by
low density lung tissue) as central.
Troeller et al. Radiation Oncology  (2015) 10:51 Page 2 of 8Background
The use of high accuracy dose calculation algorithms,
such as Monte Carlo (MC) and Collapsed Cone (CC)
has increased during the past few years due to increased
speed of the algorithms and availability of advanced
computational technology. These algorithms are capable
of estimating dose in inhomogeneous media more accur-
ately than simpler dose calculation algorithms of pencil
beam (PB) type. It is well known that the pencil beam al-
gorithms lack accurate modeling of lateral scatter and
-backscatter, because they neglect tissue density inhomo-
geneity in directions other than the beam and assume
water density instead. In contrast, CC and MC include
more accurate inhomogeneity corrections [1]. MC simu-
lations, which explicitly model particle interactions and -
transport in the patient, are generally considered the
gold standard of dose calculation. A popular choice for
dose calculation are CC based algorithms that approxi-
mately model lateral scattering and -backscatter via
density dependent anisotropic rescaling of pre-calculated
point kernels for effects from secondary particle trans-
port. In the following, we investigate dose calculation
differences between PB and CC, which are the two dose
calculation algorithms choices implemented in our clin-
ical 3D-CRT treatment planning system (TPS) Oncentra
MasterPlan® (OTP, Version 4.2, Nucletron).
Differences in dose calculation accuracy in the patient
between the different algorithms can be expected to be
most predominant in anatomic regions with large local tis-
sue density inhomogeneities and density discontinuities,
such as small lung lesions surrounded by low density lung
tissue. When stereotactic radiotherapy of intrapulmonary
lesions was first introduced into routine clinical treatment,
most institutions calculated dose distributions using dose
calculation programs based on PB type algorithms. How-
ever, it is now widely and clinically accepted that dose cal-
culation algorithms of the PB type generally do not
provide enough accuracy for dose calculation in inhomo-
geneous tissue [2]. Recent recommendations for the im-
plementation of stereotactic ablative radiotherapy (SABR)
of lung cancer therefore include the use of those adapted
algorithms. However, historically, prescription schemes
were based on clinical experience with PB. Recent guide-
lines such as the ICRU (ICRU-62, Bethesda, Md, USA,
1999) recommend similarly strict requirements for treat-
ment plans calculated with CC or MC. Because of the in-
sufficient modeling of lateral scattering and -backscatter,
the dose to the tumor is usually overestimated when using
PB and the same plan may indicate lower dose when
recalculated with CC [3,4]. This will lead to treatment
plans with changes in field size and MUs delivered, as well
as changes in dose to organs at risk (OAR) when creating
a treatment plan based on a CC dose calculation algo-
rithm without proper adjustment of the prescription.In order to quantify differences between dose distribu-
tions calculated with PB and CC in patients treated at
our institution, we examined treatment plans of patients
that received SABR of intrapulmonary lesions. These
patients usually have smaller tumors and may show
large discrepancies between dose calculated with PB
and CC. There is a variety of different implementations
of PB algorithms, that may differ in how severely cal-
culated dose differs from delivered dose as estimated
with CC. In this study we investigate the enhanced PB
and CC algorithms used in the Oncentra MasterPlan®
treatment planning system.
Methods
The treatment plans of 17 patients treated for small
intrapulmonary lesions at our institution between 2008
and 2010 were retrospectively evaluated (Table 1). For
each patient 3 computed tomography (CT) scans with a
3 mm slice gap were acquired prior to treatment: a free-
breathing scan, a maximum inhale and a maximum ex-
hale scan. The scans were then imported to the Oncentra
MasterPlan® treatment planning system (Version 4.2,
Nucletron). The gross tumor volume (GTV) was con-
toured on each of the CT scans and an internal target
volume (ITV) was defined by forming the union of all
GTVs. The planning target volume (PTV) was created
from the ITV, by adding a 7 mm margin laterally and
9 mm in the cranial-caudal direction. For all patients, a
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to the planning target volume (PTV) in single fractions
of 7.5 Gy, such that the 80% isodose line completely
covered the PTV.
All dose calculations were performed on the free-
breathing CT scan without density overrides. The 3D
conformal, un-modulated treatment plans were designed
for a Siemens Oncor treatment unit with a 10 mm leaf-
width multi-leaf collimator (MLC). Mixed photon energy
was used (6 and 15 MV) incorporating 7 beams on aver-
age. The beam model was verified against experiment
and accepted for clinical use.
The dose distributions of the original treatment plans
were calculated using OTP’s enhanced pencil beam (PB)
algorithm. For the purpose of this study, all plans were
recalculated with the “enhanced CC” algorithm imple-
mented in OTP (CCre-calc), without altering the field
shape, field size, beam setup, or monitor units. Further-
more we created two additional plans calculated with
CC for each patient: A plan that resembles what would
currently be considered acceptable for a patient in our
clinic (CCclin) and a stricter second plan (CCcov) that ob-
tained coverage similar to the original PB plan. The
former constitutes a clinically accepted compromise in
our institution that may formally violate the PTV cover-
age criteria mentioned above in low density parts of the
PTV where full dose build-up is difficult to realize for
physical reasons. The latter was created to demonstrate
how dose to organs at risk would change in the hypo-
thetical scenario of switching from a PB algorithm to a
CC algorithm without adapting the criteria for an ac-
ceptable plan.
For the CCclin and CCcov plans MUs as well as field
size and shape had to be adjusted accordingly. For the
CCcov the fields were opened in beam’s eye view (BEV)
until coverage was achieved, while for the CCclin the dis-
tance between the jaws and the PTV-outline were not to
exceed 1 cm in BEV. All four plans per patient were then
compared to each other. Parameters used for comparison
were volume coverage (V60Gy), mean dose (Dmean), dose
received by 99% and 1% of the volume (D99 and D1), mini-
mum dose (Dmin), and maximum dose (Dmax) for the
GTV, ITV and PTV. Estimated coverage in dependence
on GTV volume was also considered. Furthermore we
evaluated Dmean, V20Gy and V10Gy to the lungs, Dmean to
the heart and Dmax to the spinal cord and esophagus. Both
lungs were contoured as one organ including the PTV.
The adjusted CCclin and CCcov treatment plans were fur-
ther analyzed regarding alterations of MU and field size
compared to the original PB plan. The influence of tumor
position and movement on coverage was briefly investi-
gated. For the purpose of this study we defined tumors
that were directly attached to the mediastinum or pleura
as peripheral and all others as central. Statisticalsignificance of the differences between parameters calcu-
lated with PB and parameters calculated with CCre-calc,
CCclin and CCcov was determined using the Wilcoxon
signed-rank test (p < 0.05 signifies significant difference).
Correlation of the difference in target coverage between
PB and CC (i.e. V60 Gy,PB – V60Gy,CC) with the target ROI
volumes was determined using Spearman’s rank correl-
ation coefficient, ρ. The significance of the correlation was
verified with Spearman’s rank test, with the null hypoth-
esis H0, that ROI volume and difference in coverage are
independent and alternative hypothesis Ha, that they are
dependent. Analysis of the parameters and statistical ana-
lyses were performed in Mathematica (Wolfram Research,
Inc., Mathematica, Version 9.0.1, Champaign, IL (2013)).
Results and discussion
Original PB plan vs. CCre-calc
For the target structures GTV, ITV and PTV all evalu-
ated parameters (V60Gy, Dmean, Dmin, Dmax, D99, D1) were
significantly lower for the plans that were re-calculated
based on the CC algorithm (CCre-calc) as opposed to the
original ones incorporating the PB algorithm (p < 0.001).
All OAR parameters considered in this study (p < 0.01),
except Dmax to the spinal cord, were statistically signifi-
cantly lower when the PB plan was recalculated with CC.
However, the differences regarding heart and spinal cord
were of relatively small magnitude and may not be clinic-
ally relevant.
The results for all structures are shown in Table 2.
The GTV, ITV and PTV coverage with 60 Gy and
higher as well as D99 and Dmax versus the GTV, ITV and
PTV volume for both PB and CCre-calc treatment plans
are shown in Figures 1 and 2. For the PTV, a larger dis-
crepancy between PB and CC coverage is significantly
correlated with a smaller ROI volume (ρPTV = −0.77,
pPTV < 0.001), while for the GTV and ITV the correl-
ation coefficient is less pronounced and not significant
(ρITV = −0.43, pPTV = 0.08, ρGTV = −0.18, pGTV = 0.49).
Large difference of Dmin, D99, Dmax and D1 between PB
and CC is significantly correlated with ROI volume for
all three target ROIs: GTV, ITV and PTV.
There was considerable variability of the dose volume
parameters of GTV, ITV and PTV between patients,
likely due to tumor volume and position. As expected
the differences were more pronounced for tumors com-
pletely surrounded by lung tissue and not adherent to
pleural or mediastinum tissues. For example, the differ-
ence in average GTV relative volume covered by 60 Gy
or more was 3.5% for peripheral tumors compared to
6.1% for centrally located tumors. Presumably, this is
due to the fact that the density of the chest wall and me-
diastinal tissue is closer to the density of water, than the
low density lung tissue. Therefore the PB algorithm,
which assumes water density laterally, estimates dose
Table 2 Dose and volume parameters for targets and organs at risk for pencil beam and cc calculations
ROI Parameter PB CCre-calc CCcov CCclin
GTV V60Gy (%) 99.8 ± 0.9 86.6 ± 26.5 99.6 ± 1.0 99.4 ± 1.5
Dmean (Gy) 73.7 ± 1.6 67.0 ± 4.4 72.8 ± 1.5 72.5 ± 1.6
Dmin (Gy) 63.1 ± 11.0 51.4 ± 9.6 61.3 ± 8.5 59.5 ± 9.6
D99 (Gy) 67.9 ± 7.1 56.8 ± 7.6 65.5 ± 5.4 64.2 ± 6.3
Dmax (Gy) 76.8 ± 1.4 71.6 ± 4.0 76.6 ± 1.3 76.6 ± 1.3
D1 (Gy) 76.4 ± 1.4 71.3 ± 3.9 76.3 ± 1.3 76.4 ± 1.3
ITV V60Gy (%) 99.6 ± 1.7 79.8 ± 30.4 98.4 ± 4.3 97.3 ± 5.7
Dmean (Gy) 73.3 ± 1.7 64.8 ± 5.2 71.0 ± 2.1 70.6 ± 2.3
Dmin (Gy) 60.6 ± 12.4 47.7 ± 11.0 57.9 ± 11.7 56.3 ± 11.7
D99 (Gy) 66.0 ± 10.5 53.2 ± 9.9 62.1 ± 8.6 60.7 ± 9.4
Dmax (Gy) 77.0 ± 1.5 71.6 ± 4.0 76.6 ± 1.3 76.6 ± 1.3
D1 (Gy) 76.7 ± 1.4 71.1 ± 4.0 76.2 ± 1.2 76.2 ± 1.2
PTV V60Gy (%) 95.1 ± 1.9 55.7 ± 27.0 90.9 ± 12.5 85.5 ± 15.3
Dmean (Gy) 69.9 ± 1.3 60.0 ± 5.7 67.4 ± 2.6 66.6 ± 3.1
Dmin (Gy) 43.4 ± 4.9 35.8 ± 3.9 49.2 ± 4.4 46.4 ± 5.2
D99 (Gy) 55.0 ± 1.9 44.3 ± 5.3 56.7 ± 3.7 54.2 ± 4.5
Dmax (Gy) 77.0 ± 1.5 71.6 ± 4.0 76.6 ± 1.3 76.6 ± 1.3
D1 (Gy) 76.5 ± 1.4 70.7 ± 4.1 75.8 ± 1.2 75.8 ± 1.2
Lungs V20 Gy (%) 7.6 ± 4.3 6.8 ± 4.2 9.6 ± 5.0 8.9 ± 4.9
V10 Gy (%) 14.3 ± 5.7 13.4 ± 6.3 17.4 ± 6.6 16.3 ± 6.5
Dmean (Gy) 5.3 ± 2.1 5.0 ± 2.0 6.6 ± 2.3 6.1 ± 2.3
Heart Dmean (Gy) 3.0 ± 3.5 2.9 ± 3.5 3.6 ± 3.5 3.4 ± 3.5
Spinal cord Dmax (Gy) 8.3 ± 8.8 8.1 ± 8.5 10.9 ± 9.6 10.3 ± 9.6
Esophagus Dmax (Gy) 17.6 ± 9.7 16.9 ± 8.9 19.6 ± 10.6 19.3 ± 10.3
Figure 1 Target coverage versus target volume for a) gross tumor volume (GTV), b) ITV and c) planning target volume (PTV); d) shows
GTV coverage versus the ratio of ITV and GTV volume which is indicative of tumor movement. The black markers indicate the original
values calculated with pencil beam (PB), while the red and green markers show the recalculated collapsed cone (CCre-calc) patients with central
tumors (red) and tumors attached to mediastinum or pleura (green).
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Figure 2 D99 versus the total absolute volume for a) GTV, b) ITV and c) PTV; d) shows the maximal dose versus the total GTV volume.
The black markers indicate the original values calculated with pencil beam (PB), while the red and green markers show the recalculated collapsed
cone (CCre-calc) patients with central tumors (red) and tumors attached to mediastinum or pleura (green).
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tissue than in those surrounded mainly by air.
In one extreme case of a central tumor with very small
volume the GTV V60Gy was reduced from 100% to 26%,
Dmean from 74.2 Gy to 57.9 Gy and D99 from 71.6 Gy to
49.9 Gy. The PTV coverage was tremendously reduced
from 96% to 3.6%. The DVHs of this patient are shown
in Figure 3. Dose distributions of this patient and an-
other less extreme case with larger tumor volume close
to the posterior chest wall are shown in Figure 4.
No correlation was found between tumor movement
(which was quantified by the ratio of ITV volume to
GTV volume) and difference in GTV coverage (Figure 1
bottom, right, ρ = 0.12, p = 0.63). However, this result
may be limited to our study and a more rigorous ana-
lysis is necessary to evaluate the impact of tumor motion
on dose distribution in general, for example by perform-
ing a 4D dose calculation study similar to Guckenberger
et al. [5].
PB vs. CCclin and CCcov
For the GTV there was no statistically significant differ-
ence in Dmean, Dmin, Dmax, D99, D1 when comparing PB
to the plan with similar coverage (CCcov). By design,
there was no difference in coverage (V60Gy). For PTV,
there was a significant difference in Dmean, Dmin, D99
and D1, but not in terms of coverage and Dmax. In order
to achieve similar coverage, MUs delivered and field size
in X and Y direction had to be adjusted. Total MUs and
average field size in x and y direction were significantly
larger in the CCclin and CCcov plans (p < 0.001, Table 3).
Fields were more often adjusted craniocaudally.In current clinical practice we use the enhanced CC al-
gorithm to calculate dose, and the field size is allowed to
increase up to a distance of 10 mm between the jaws
and the outer PTV margin in BEV (compared to 5 mm
in former plans calculated with PB) to achieve more ad-
equate calculated GTV coverage. Therefore, the clinic-
ally accepted plans CCclin had acceptable GTV coverage
that was not different from coverage calculated with the
original PB. However, CCclin plans had decreased Dmin
and D99 for the GTV.
The field size is usually not increased enough to also
achieve the same planned PTV coverage as with PB, es-
pecially in areas mainly consisting of air. Thus, by con-
struction, PTV values do not reach values of the original
PB plan for CCclin plans.
All evaluated parameters for the OAR were signifi-
cantly larger in the CCcov plan than PB and conse-
quently in CCre-calc. This is due to the increased monitor
units and field sizes necessary to achieve similar calcu-
lated target coverage for the CCcov plan compared to the
PB plan.
The results for the CCcov and CCre-calc plans imply
that when switching dose calculation algorithms from
PB to CC without changing the criteria for an acceptable
treatment plan, the OAR will be exposed to increased
dose. This is because when using CC the same plan
quality in terms of reported target coverage (especially
in the PTV) can only be achieved by increasing MU and
field size, which leads to higher dose to OAR. Although
the CC calculated dose is closer to the truly delivered
dose and thus preferable over PB, many OAR constraints
originate from experience with PB. While some of the
Figure 3 Dose volume histograms of GTV, PTV, lungs, heart, spinal cord and esophagus for a patient with extreme differences
between PB and CC distributions. The solid, dashed, dotted and dashed-dotted lines represent the PB, CCre-calc, CCcov and CCclin
plans respectively.
Troeller et al. Radiation Oncology  (2015) 10:51 Page 6 of 8available recommendations for lung SBRT may suggest
adaptation of the dose prescription according to the type
of dose-calculation algorithm used that is not nearly al-
ways the case for clinical recommendations [6].
The difference between dose estimates by using PB
and CC in target structures is especially pronounced in
the PTV, because the PTV contains tumor tissue as well
as air in the planning CT and thus includes large vari-
ation of tissue density. Our data is in the range of previ-
ously reported works by Haedinger et al. [7], who found
a decrease in Dmean of 11.2% whereas 14.2% was found
in our study. However, we found a much more drastic
change in average PTV coverage of 39.4 volume % com-
pared to 7.1 volume % found by Haedinger et al., who
used the Helax-TMS treatment planning system. It is
therefore essential to keep stressing the importance of
the choice of suitable dose calculation algorithms. Al-
though there are a variety of studies that have investi-
gated implications of using PB type versus CC type dose
calculation algorithms (e.g. [7,8]), most publications on
the matter consider the PTV and CTV mainly orexclusively. However, Guckenberger et al. [5] have
shown that the 4D dose calculated over all breathing
phases in the GTV is similar to the dose in the GTV in
one single phase for 3D conformal plans (end-exhal-
ation, end-inhalation, or mid-ventilation phase). This
means that the GTV may really be the relevant ROI for
evaluating such differences resulting from dose calcula-
tion algorithms assuming that the fields are opened
enough to allow coverage of the GTV in all phases. The
present study therefore also includes data for the GTV.
Aarhup and Dobler [3,4] demonstrated discrepancies
in mixed-density phantom studies. They showed that PB
algorithms tend to overestimate the target dose, while
CC and MC seemed to provide more reliable data com-
pared to measurements. Latifi et al. [9] demonstrated
that there was a significantly higher rate of reoccurrence
when SABR plans were planned using a PB algorithm
for dose calculation than if CC was used.
The performance of dose calculation algorithms in
lung depends on the use of different patient models [10]
in order to account for target motion in the presence of
Figure 4 Sagittal, coronal and transversal CT view of two sample patients. The top slices show the most extreme case (Patient 2) due to
the small tumor volume, whereas the bottom slices depict a less extreme case. Pencil beam (PB) is shown on the left and the plans recalculated
with collapsed cone (CCre-calc) on the right. The orange, yellow, bright green, light green, light blue, medium blue, turquoise and dark blue lines
represent the 75 Gy, 67.5 Gy, 60 Gy, 52.5 Gy, 45 Gy, 37.5 Gy, 30 Gy and 15 Gy isodoses, respectively
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average CTs, CTs with density overrides, maximum in-
tensity projection) [11,12]. For the purpose of this study,
we performed dose calculation only on a single static
planning CT, which is the current clinical practice in our
institution for lung SABR treatment planning using
Oncentra MasterPlan®. Furthermore, it should be noted
that both the quality of the beam model and the TPS-
specific implementation of the head model can influence
the performance of different dose calculation algorithms
and impact the calculated dose distribution. The results
obtained in this study may therefore be specifically use-
ful for OTP users. For the purpose of our study we used
PB- and CC-beam models that were carefully verifiedTable 3 Relative change in average total monitor units
with respect to PB plans and average field size
PB CCcov CCclin
Average relative change of total MU (%) - 5.0 ± 5.6 5.8 ± 5.9
Average field size X (cm) 4.6 ± 1.3 5.0 ± 1.3 4.9 ± 1.3
Average field size Y (cm) 6.5 ± 1.9 7.2 ± 1.9 6.9 ± 2.0with respect to base data measurements prior to clinical
use in our institution.
The large discrepancies resulting from use of different
dose calculation algorithms are of special importance
when multi-institutional studies are performed. A com-
parative planning study for the JCOG 0403 protocol
showed notable differences between the participating in-
stitutions for Dmax, Dmin, D95, and the homogeneity index
of the PTV, although target definitions and target dose
constraints were the same. These inter-institutional devia-
tions were mainly attributed to the different choice of dose
calculation algorithms used in the institutions [13]. Even if
only CC algorithms are used, their quality may depend on
the exact implementation of the algorithm in the treat-
ment planning system, and be specific to the release ver-
sion [14,15]. The use of a wide variety of dose prescription
modes in stereotactic radiotherapy leads to additional in-
transparency when comparing data [16].
More recently started studies require tissue density het-
erogeneity correction. For RTOG 0236, SBRT conformal
treatment plans were generated using XiO/superposition
meeting dosimetric compliance criteria recommended for
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heterogeneity correction was applied in the initial calcula-
tions. V20Gy increased on average by 18% in the MC
plans [17]. Although CC algorithms predict dose more ac-
curately than PB algorithms, they can nevertheless deviate
from measured dose and dose calculated with MC. Several
studies investigated deviations of CC algorithms from
measured dose or dose calculated with MC (e.g. [2,15,18]).
Krieger et al. [2] and Kry et al. [18] found good agreement
between MC and measured dose. Thus, in order to fully
evaluate the implications of using PB and CC algorithms
in the clinic, a comparison with MC would be necessary.
Conclusions
The use of different calculation algorithms leads to sig-
nificant changes not only in dose, but also in field size
and MUs delivered, if similar target coverage criteria are
applied for treatment planning. This has to be taken into
account for treatment planning and comparison of data
concerning side effects as well as local control in radio-
therapy of intrapulmonary lesions. Using CC improves
the accuracy of dose calculation in the tumor. However,
attempting to cover the parts of the PTV and ITV that
mainly consist of air, caused a higher strain on the lung
and OARs in our study. In cases with borderline accept-
able OAR exposition, CC plans should be evaluated
cautiously.
If data concerning safety margins, OAR limits, maximum
or mean dose and PTV/ITV coverage of radiotherapy
plans in stereotactic radiotherapy are compared, it is of
interest to state which dose calculation algorithm was
used. Future projects will include comparison of the
resulting CC and PB dose distributions to the MC gold
standard, as dose calculated with CC itself can deviate
from measured values. Also evaluation of accumulated 4D
dose may be necessary to estimate the actual increase of
TCP that can be achieved by trying to obtain PTV cover-
age with CC.
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